PROPRIETARY ARGININE VASOPRESSIN RECEPTOR TYPE 1A (AVPR1A) ANTAGONISTS FOR TREATMENT OF LETHAL PROSTATE CANCER

$1,272,102FY2025Defense Health AgencyDOD

University Of Miami, Coral Gables FL

Investigators